About this episode
Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- AstraZeneca shares rise after the pharmaceutical giant said it is stopping a clinical trial of the experimental drug volrustomig after it didn’t look set to help fight lung cancer better than existing therapies.
- Glencore shares rise after Export-Import Bank of Korea announced it will lend $1 billion to the commodities giant in exchange for copper supply to South Korean companies, as the country seeks to secure raw materials needed for the artificial intelligence boom.
- Argenx jumps as much as 10%, the most in more than a year, after the company announced positive late-stage trial results for its experimental myositis treatment.
See omnystudio.com/listener for privacy information.
Get every episode summarized
Each time Stock Movers publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Stock Movers
Apple Debuts Foldable Phone, AeroVironment Drops, Abercrombie Reports
Stock Movers
Apple Debuts New Phone, Meta Gains, Signet Soars
Stock Movers
UnitedHealth Falls, Booking Drops, Dell Jumps as it Seeks to Raise $4 Billion Fr...
Stock Movers
Meta Gains, Casey's Falls, ServiceTitan Tumbles After 2Q Loss
Stock Movers